The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Impact of objective response and overall survival in patients with inoperable or metastatic gastric and esophagogastric junction (EGJ) cancer: Landmark analysis of 10-year data from first-line clinical trials.
Toki Anna Bolt
No relevant relationships to disclose
Claudia Pauligk
No relevant relationships to disclose
Dominique Werner
No relevant relationships to disclose
Ralf Dieter Hofheinz
No relevant relationships to disclose
Frank Mayer
No relevant relationships to disclose
Kim Barbara Luley
No relevant relationships to disclose
Nils Homann
No relevant relationships to disclose
Harald Schmalenberg
No relevant relationships to disclose
Matthias Egger
No relevant relationships to disclose
Salah-Eddin Al-Batran
No relevant relationships to disclose